| MeSH term | MeSH ID | Detail |
|---|---|---|
| Microvascular Angina | D017566 | 2 associated lipids |
| Carcinoma, Lobular | D018275 | 4 associated lipids |
| Chronic Disease | D002908 | 7 associated lipids |
| Leishmaniasis, Cutaneous | D016773 | 6 associated lipids |
| Carcinosarcoma | D002296 | 7 associated lipids |
| Arthritis, Reactive | D016918 | 3 associated lipids |
| Carcinoid Heart Disease | D002275 | 1 associated lipids |
| Hyperphosphatemia | D054559 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Verde ME et al. | Effect of Bisphosphonates on the Levels of Rankl and Opg in Gingival Crevicular Fluid of Patients With Periodontal Disease and Post-menopausal Osteoporosis. | 2015 | Acta Odontol Latinoam | pmid:27095621 |
| Board-Davies E et al. | Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin. | 2015 | Stem Cells Transl Med | pmid:26378260 |
| Kato G et al. | The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study. | 2015 | Arthritis Res. Ther. | pmid:26373710 |
| Li CW et al. | Opg/Rankl mRNA dynamic expression in the bone tissue of ovariectomized rats with osteoporosis. | 2015 | Genet. Mol. Res. | pmid:26345854 |
| Fernández-González FJ et al. | Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review. | 2015 | Dental Press J Orthod | pmid:26560822 |
| Telejko B et al. | The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes. | 2015 | Ann Agric Environ Med | pmid:26094529 |
| Ketlogetswe KS et al. | Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men. | 2015 | J. Acquir. Immune Defic. Syndr. | pmid:26090754 |
| Burton LJ et al. | Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. | 2015 | Carcinogenesis | pmid:26069256 |
| Folestad A et al. | Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients. | 2015 | Acta Orthop | pmid:25811776 |
| Sutton KM et al. | The functions of the avian receptor activator of NF-κB ligand (RANKL) and its receptors, RANK and osteoprotegerin, are evolutionarily conserved. | 2015 | Dev. Comp. Immunol. | pmid:25796577 |
| Zheng Y et al. | Mesenchymal dental pulp cells attenuate dentin resorption in homeostasis. | 2015 | J. Dent. Res. | pmid:25762594 |
| Rao M et al. | Osteoclasts are dispensable for hematopoietic progenitor mobilization by granulocyte colony-stimulating factor in mice. | 2015 | Exp. Hematol. | pmid:25461255 |
| Estanislau IM et al. | Pleiotropic effects of statins on the treatment of chronic periodontitis--a systematic review. | 2015 | Br J Clin Pharmacol | pmid:25444240 |
| Esteghamati A et al. | Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. | 2015 Aug-Sep | Arch Cardiovasc Dis | pmid:26184866 |
| SaÄŸlam M et al. | Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. | 2015 Jan-Feb | J Appl Oral Sci | pmid:25760266 |
| Sasso GR et al. | Elevated serum osteoprotegerin levels in women: friend or foe? | 2015 Nov-Dec | Rev Assoc Med Bras (1992) | pmid:26841162 |
| Calasans-Maia MD et al. | Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814461 |
| Jianru YI et al. | Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. | 2015 Nov-Dec | J Appl Oral Sci | pmid:26814456 |
| Zhang L et al. | Effects of IL-10 and glucose on expression of OPG and RANKL in human periodontal ligament fibroblasts. | 2016 | Braz. J. Med. Biol. Res. | pmid:27074164 |
| Song DH et al. | Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis. | 2016 | Med. Sci. Monit. | pmid:27068490 |
| Kose O et al. | Influences of Fucoxanthin on Alveolar Bone Resorption in Induced Periodontitis in Rat Molars. | 2016 | Mar Drugs | pmid:27043583 |
| Shah AP et al. | Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. | 2016 | PLoS ONE | pmid:27019421 |
| Dela Cruz A et al. | Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:27006198 |
| Lis GJ et al. | Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. | 2016 | Pol. Arch. Med. Wewn. | pmid:27003233 |
| Tsuruda T et al. | Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice. | 2016 | Hypertension | pmid:27001297 |
| Kats A et al. | Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. | 2016 | J. Cell. Mol. Med. | pmid:26987561 |
| Moran CS et al. | Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. | 2016 | Arterioscler. Thromb. Vasc. Biol. | pmid:26966276 |
| Li N et al. | Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. | 2016 | Pharmazie | pmid:29441931 |
| Yuan SY et al. | Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. | 2016 | Chin J Nat Med | pmid:27114313 |
| Johnson DC et al. | Genetic factors influencing the risk of multiple myeloma bone disease. | 2016 | Leukemia | pmid:26669972 |
| Davaine JM et al. | Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. | 2016 | Eur J Vasc Endovasc Surg | pmid:26652270 |
| Li J et al. | Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro. | 2016 | Mol Med Rep | pmid:26647856 |
| Cervellati C et al. | Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia. | 2016 | Oxid Med Cell Longev | pmid:26635910 |
| Alam I et al. | Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. | 2016 | Endocrinology | pmid:26584014 |
| Zhao N et al. | Isolation and Functional Analysis of an Immortalized Murine Cementocyte Cell Line, IDG-CM6. | 2016 | J. Bone Miner. Res. | pmid:26274352 |
| Liu YD et al. | Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. | 2016 | Osteoarthr. Cartil. | pmid:26256766 |
| Wang S et al. | Anti-inflammatory and anti-arthritic effects of taraxasterol on adjuvant-induced arthritis in rats. | 2016 | J Ethnopharmacol | pmid:27109342 |
| Bergamini A et al. | Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. | 2016 | Int J Med Sci | pmid:28090190 |
| Liu HJ et al. | Substance P Promotes the Proliferation, but Inhibits Differentiation and Mineralization of Osteoblasts from Rats with Spinal Cord Injury via RANKL/OPG System. | 2016 | PLoS ONE | pmid:27764190 |
| Menzel J et al. | Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator. | 2016 | J. Endocrinol. Invest. | pmid:27614458 |
| O'Sullivan S et al. | Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. | 2016 | PLoS ONE | pmid:27737004 |
| Li M et al. | Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis. | 2016 | J. Biol. Chem. | pmid:27697839 |
| Shirakawa J and Kulkarni RN | Novel factors modulating human β-cell proliferation. | 2016 | Diabetes Obes Metab | pmid:27615134 |
| Xing R et al. | Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. | 2016 | Int. J. Mol. Med. | pmid:27599586 |
| Yongdi L et al. | [Osteoprotegerin/receptor activator of nuclear factor-κB ligand expression in mandibular distraction osteogenesis regulated by parathyroid hormone]. | 2016 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:27526445 |
| Qian H et al. | FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis. | 2016 | Mol Med Rep | pmid:27510616 |
| Røysland R et al. | Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. | 2016 | PLoS ONE | pmid:27463973 |
| Piemontese M et al. | Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:27460899 |
| Zhao JJ et al. | MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. | 2016 | PLoS ONE | pmid:27459539 |
| Sun J et al. | Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. | 2016 | Int. Immunopharmacol. | pmid:27576059 |